Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A global standard for the testing of mycoplasma contamination has been developed

17.06.2015

Biological medicinal products such as recombinant proteins, monoclonal antibodies, and many vaccines are produced in cell cultures. Specific detection assays are performed, to make sure that these products are not contaminated with pathogens. Staff members of the Paul-Ehrlich-Institut have taken the lead in developing, on behalf of the WHO, the first internationally recognized reference preparation for tests detecting mycoplasma contamination in cell cultures. The journal “Applied and Environmental Microbiology” reports on this newly developed WHO standard in its online edition of 12 June 2015.
doi:10.1128/AEM.01150-15

Mycoplasma is a genus of very small bacteria that lack a cell wall. Due to their very small size and their flexible shape, these pathogens are able to pass bacteria filters and, for this reason cannot be safely removed by means of such filters during the manufacture of medicinal products. Mycoplasma include species which cause diseases of the respiratory and urogenital tracts in humans.


Mycoplasma-contaminated cell culture

Prof. Dr. Renate Rosengarten, University of Veterinary Medicine, Vienna & Mycoplasma Biosafety Services GmbH

Various test methods are applied to ascertain that neither the original cells used for the production of biological medicinal products – the so-called master cell banks – nor the production cells themselves are contaminated with mycoplasma bacteria.

One of the most sensitive test methods is the nucleic acid amplification technique (NAT). It involves amplification of sections of the bacterial genome by a billion, enabling the detection of the pathogenic agent. As with other test methods, a prerequisite for test reliability is its verification using suitable reference materials – so-called WHO International Standards (IS).

Coworkers of PD Dr Micha Nübling, head of the Section Molecular Virology of the Division Virology at the Paul-Ehrlich-Institut, have developed the first IS for NAT testing for mycoplasma (“1st WHO IS for mycoplasma DNA for NAT assay designed for generic mycoplasma detection”).

The Section at the PEI forms part of the WHO Collaborating Centre for Quality Assurance of Blood Products and in vitro Diagnostic Devices at the institute. Part of the development process of the IS involved an international feasibility study, in which four distantly related mycoplasma species were assayed in different concentrations by 21 laboratories using 26 NAT methods.

Based on the results obtained from these studies, the WHO standard was designed and manufactured and finally established by the WHO “Expert Committee on Biological Standardization (ECBS)”. Professor Klaus Cichutek, president of the Paul-Ehrlich-Institut, is a member of the ECBS.

This WHO IS is now available for the determination of quality features of NAT tests (e.g. the detection limit), the calibration of quantitative assays and the definition of regulatory requirements for mycoplasma testing. “We are pleased that we have succeeded in developing this WHO standard, which will contribute to making worldwide test methods for the detection of mycoplasmas - more reliable and comparable with each other“, says PD Dr Micha Nübling.

Original Publication
Nübling CM, Baylis SA, Hanschmann KM, Montag-Lessing T†,
Chudy M, Kreß J, Ulrych U, Czurda S, Rosengarten R, and
the Mycoplasma Collaborative Study Group (2015): World Health Organization International Standard to Harmonize Assays for Detection of Mycoplasma DNA. Appl Environ Microbiol. 2015 Jun 12. pii: AEM.01150-15
doi:10.1128/AEM.01150-15


The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines in Langen near Frankfurt/Main, is a senior federal authority reporting to the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG). It is responsible for the research, assessment, and marketing authorisation of biomedicines for human use and veterinary vaccines. Its remit also includes the authorisation of clinical trials and pharmacovigilance, i.e. recording and evaluation of potential adverse effects. Other duties of the institute include official batch control, scientific advice and inspections. In-house experimental research in the field of biomedicines and life science form an indispensable basis for the varied and many tasks performed at the institute. The PEI, with its roughly 800 staff, also has advisory functions at a national level (federal government, federal states (Länder)), and at an international level (World Health Organization, European Medicines Agency, European Commission, Council of Europe etc.).

Weitere Informationen:

http://www.ncbi.nlm.nih.gov/pubmed/?term=World+Health+Organization+International... - Abstract
http://aem.asm.org/content/early/2015/06/08/AEM.01150-15.full.pdf - Fulltext Accepted Manuscript

Dr. Susanne Stöcker | idw - Informationsdienst Wissenschaft

More articles from Life Sciences:

nachricht New application for acoustics helps estimate marine life populations
16.01.2018 | University of California - San Diego

nachricht Unexpected environmental source of methane discovered
16.01.2018 | University of Washington Health Sciences/UW Medicine

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

Im Focus: A thermometer for the oceans

Measurement of noble gases in Antarctic ice cores

The oceans are the largest global heat reservoir. As a result of man-made global warming, the temperature in the global climate system increases; around 90% of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Gran Chaco: Biodiversity at High Risk

17.01.2018 | Ecology, The Environment and Conservation

Only an atom thick: Physicists succeed in measuring mechanical properties of 2D monolayer materials

17.01.2018 | Physics and Astronomy

Fraunhofer HHI receives AIS Technology Innovation Award 2018 for 3D Human Body Reconstruction

17.01.2018 | Awards Funding

VideoLinks
B2B-VideoLinks
More VideoLinks >>>